Is bntx a good stock to buy?

BNTX is trading within a range we consider fairly valued. BioNTech's pipeline, which relies on expertise in mRNA and bioinformatics, will be difficult to replicate by competitors. BioNTech's technology is still relatively new, with no oncology approvals to establish use in this setting. Is it the right time to buy, sell, or hold?

What is the target price for biontech se (bntx)?

Since most investors and traders follow analyst ratings closely, this can be a potentially driving factor for the future stock price of BioNTech SE. The Average Price target for BNTX set by the institutional analysts is $332.39 where High Estimate is $472.50, Median $336.6 and Low $181.80.

Did JPMorgan downgrade biontech se (bntx)?

Investing.com -- U.S.-listed shares in BioNTech (NASDAQ:BNTX) dipped in early trading on Friday after analysts at JPMorgan downgraded their rating of the vaccine maker to "underweight" from "neutral." Find the latest BioNTech SE (BNTX) stock quote, history, news and other vital information to help you with your stock trading and investing.